The study is published in Biosensors and Bioelectronics.. As tumors develop, they shed cells into the bloodstream. Although ...

Lead image: Science Photo Library / Getty Images. ... Cite this: How Useful Are Circulating Tumor Cells for Early Diagnosis? - Medscape - Aug 08, 2023. Comments. Commenting is limited to ...

Circulating tumor biomarkers, designated liquid biopsies, 1 are gaining an important role in the prognosis, prediction, and treatment monitoring of patients with malignancies. 2,3 Circulating tumor ...

Reference: Würth R, Donato E, Michel LL, et al. Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1–HER3 signaling. Nat Cancer. 2025:1-19. doi: ...

Circulating tumor cells (CTCs) are considered precursors to metastasis. They mirror tumor heterogeneity and can be found in the bloodstream as either single CTCs or clusters. Non-invasive liquid ...

Investigators have designed an antibody-based treatment that eliminated circulating tumor cells (CTCs) in mouse models of breast and pancreatic cancer. The research, which was led by scientists at ...

Nagrath’s team of researchers developed the ‘GO chip’ in 2013, which succeeded where other tests fell short by trapping only circulating tumor cells (CTCs).

Finding ways to attack these circulating tumor cells (CTCs) could prevent new tumors from taking hold, and improve patient outcomes. In 2019, scientists at ETH Zurich tested more than 2,400 ...

Men with no circulating tumor cells achieved significantly longer median OS (not reached) than those who had one to four circulating tumor cells (56.2 months; 95% CI, 45.7-69.8) and those who had ...